Histologic confirmation of Renal cell carcinoma (RCC) with a clear cell component

Previous treatment with at least one anti-angiogenic agent

Progressed within 6 months of study enrollment

Subjects should not have had more than 3 prior treatments for locally advanced or metastatic disease

Must have available tumor tissue for submission

Subjects must also meet various laboratory parameters for inclusion

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)